Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
Journal of the National Cancer Institute. Monographs|January 1, 1993
A reassessment of cardiac toxicity associated with TaxolS G Arbuck, H Strauss, E Rowinsky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinomaR Pazdur, E Diaz-Canton, W P Ballard, et al.Cancer|March 1, 1979
Selectivity of the micro-leukocyte adherence inhibition assay in pancreatic cancerH O Douglass, A J Russo, J H Howell, et al.Investigational New Drugs|July 30, 1999
Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinomaR Pazdur, D C Medgyesy, R J Winn, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1991
Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's diseaseZ P Bernstein, L Vaickus, N Friedman, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1991
Interleukin-2 with ex vivo activated killer cells: therapy of advanced non-small-cell lung cancerZ P Bernstein, M H Goldrosen, L Vaickus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinomaJ L Grem, N McAtee, R F Murphy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibitionL Dudkin, M B Dilling, P J Cheshire, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumorsK N Bhalla, G N Kumar, U K Walle, et al.Cancer Research|October 15, 1993
A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinomaJ L Grem, N McAtee, S M Steinberg, et al.Pageof 7